A carregar...
LIMK2 promotes the metastatic progression of triple-negative breast cancer by activating SRPK1
Triple-negative breast cancer (TNBC) is a highly metastatic breast cancer subtype and due to the lack of hormone receptors and HER2 expression, TNBC has limited therapeutic options with chemotherapy being the primary choice for systemic therapy. LIM Domain Kinase 2 (LIMK2) is a serine/threonine kina...
Na minha lista:
| Publicado no: | Oncogenesis |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Nature Publishing Group UK
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7455732/ https://ncbi.nlm.nih.gov/pubmed/32859889 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41389-020-00263-1 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|